9.12.13-Base Pair Senior Scientist, Dr. Mark Morris has recently received a Phase I SBIR Contract from the National Cancer Institute for “Technology to Generate Anti-Peptide Capture Reagents for Affinity-Enriched Proteomic Studies“. In this project, Base Pair will generate high affinity aptamers for “pull down” of a number of peptide epitopes representing important cancer biomarkers. The resulting reagents are expected to have considerable value for assay development in cancer biology and diagnostics and will be made available in our catalog once validated.